Tris(3-[4-[3-dimethylphosphoryl-5-(2H-pyrrol-4-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine);3-[4-[2,5-dimethyl-3-(2H-pyrrol-4-yl)piperazin-1-yl]-6-methylpyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-[4-[3-(methylsulfanylmethyl)pyrrolidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine
C105H109F15N35O3P3S — CID 157217241
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tris(3-[4-[3-dimethylphosphoryl-5-(2H-pyrrol-4-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine);3-[4-[2,5-dimethyl-3-(2H-pyrrol-4-yl)piperazin-1-yl]-6-methylpyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-[4-[3-(methylsulfanylmethyl)pyrrolidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine
Tris(3-[4-[3-dimethylphosphoryl-5-(2H-pyrrol-4-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine);3-[4-[2,5-dimethyl-3-(2H-pyrrol-4-yl)piperazin-1-yl]-6-methylpyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-[4-[3-(methylsulfanylmethyl)pyrrolidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine (PubChem CID 157217241) has the molecular formula C105H109F15N35O3P3S and a molecular weight of 2319.23 g/mol. Its IUPAC name is tris(3-[4-[3-dimethylphosphoryl-5-(2H-pyrrol-4-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine);3-[4-[2,5-dimethyl-3-(2H-pyrrol-4-yl)piperazin-1-yl]-6-methylpyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-[4-[3-(methylsulfanylmethyl)pyrrolidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine.
Molecular Properties
| Compound Name | Tris(3-[4-[3-dimethylphosphoryl-5-(2H-pyrrol-4-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine);3-[4-[2,5-dimethyl-3-(2H-pyrrol-4-yl)piperazin-1-yl]-6-methylpyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-[4-[3-(methylsulfanylmethyl)pyrrolidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine |
|---|---|
| PubChem CID | 157217241 |
| Molecular Formula | C105H109F15N35O3P3S |
| Molecular Weight | 2319.23 g/mol |
| Exact Mass | 2317.81 |
| IUPAC Name | tris(3-[4-[3-dimethylphosphoryl-5-(2H-pyrrol-4-yl)piperidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine);3-[4-[2,5-dimethyl-3-(2H-pyrrol-4-yl)piperazin-1-yl]-6-methylpyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine;3-[4-[3-(methylsulfanylmethyl)pyrrolidin-1-yl]pyrimidin-2-yl]-6-(trifluoromethyl)imidazo[1,2-a]pyrazine |
| SMILES | CP(C)(=O)C1CC(C2=CCN=C2)CN(c2ccnc(-c3cnc4cnc(C(F)(F)F)cn34)n2)C1.CP(C)(=O)C1CC(C2=CCN=C2)CN(c2ccnc(-c3cnc4cnc(C(F)(F)F)cn34)n2)C1.CP(C)(=O)C1CC(C2=CCN=C2)CN(c2ccnc(-c3cnc4cnc(C(F)(F)F)cn34)n2)C1.CSCC1CCN(c2ccnc(-c3cnc4cnc(C(F)(F)F)cn34)n2)C1.Cc1cc(N2CC(C)NC(C3=CCN=C3)C2C)nc(-c2cnc3cnc(C(F)(F)F)cn23)n1 |
| InChI | InChI=1S/C22H23F3N8.3C22H23F3N7OP.C17H17F3N6S/c1-12-6-18(32-10-13(2)29-20(14(32)3)15-4-5-26-7-15)31-21(30-12)16-8-28-19-9-27-17(11-33(16)19)22(23,24)25;3*1-34(2,33)16-7-15(14-3-5-26-8-14)11-31(12-16)19-4-6-27-21(30-19)17-9-29-20-10-28-18(13-32(17)20)22(23,24)25;1-27-10-11-3-5-25(8-11)14-2-4-21-16(24-14)12-6-23-15-7-22-13(9-26(12)15)17(18,19)20/h4,6-9,11,13-14,20,29H,5,10H2,1-3H3;3*3-4,6,8-10,13,15-16H,5,7,11-12H2,1-2H3;2,4,6-7,9,11H,3,5,8,10H2,1H3 |
| InChIKey | ASOHMPLMYWESJN-UHFFFAOYSA-N |
| XLogP | 18.57 |
| TPSA | 408.73 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 39 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 162 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2319.23 |
| LogP ≤ 5 | 18.57 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 39 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phosphor', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157217241 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.